Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
2.970
0.00 (0.00%)
Nov 19, 2026, 4:00 PM EST - Market closed
Sionna Therapeutics Market Cap
Sionna Therapeutics has a market cap or net worth of $134.35 million as of November 19, 2026. It is the 22,648th most valuable company in the world and the 3,786th biggest in the United States. Its market cap has decreased by 92.30% in one year.
Market Cap
134.35M
Enterprise Value
-107.70M
1-Year Change
-92.30%
Global Rank
Country Rank
#3,786 United States
Category
ChartMarket Cap Chart
Since the IPO on February 7, 2025, Sionna Therapeutics's market cap has decreased from $733.61M to $134.35M, a decrease of -81.69%. That is a compound annual growth rate of -61.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 134.35M | -92.68% |
| Dec 31, 2025 | 1.84B | 150.27% |
| Feb 7, 2025 | 733.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 144.76M |
| Abeona Therapeutics | 140.01M |
| PolyPid | 138.37M |
| Adagene | 134.96M |
| Zentalis Pharmaceuticals | 133.64M |
| Yarrow Bioscience | 132.40M |
| ALX Oncology Holdings | 131.86M |
| Invivyd | 131.82M |